Aug. 17 at 11:33 PM
$CASI CASI Pharmaceuticals Announces FDA Clearance of IND Application for CID-103 in Renal Allograft Antibody-Mediated Rejection (AMR)
By ACCESSWIRE | August 04, 2025, 9:00 AM
Did you actually read all of CASI's notes in this news post? Out of all the fluff we get numerous news posts every day thru the weeks good luke warm or not so good, this actually seems like it could really be on to something. Could you imagine having a loved one needing that transplant and WERE ABLE to find one and get the swap operation done and ended up having complications from his or her body rejecting the transplanted organ? If this could aid in consistently and sustainably aiding that in every process during that whole process by going smoother and having that much more of a sure fire success rate in survival after recovery, than it would really mean a lot and be relevant for a long time its something that is actually in demand and worth it to have when were talking about something this drastic in a life
